1 The EIC Accelerator Project

EIC Accelerator Program Overview

The EIC (European Innovation Council) Accelerator program is a pivotal initiative within the European Union designed to support innovative startups and small and medium-sized enterprises (SMEs) with high growth potential. This program aims to foster the development of groundbreaking technologies and solutions, particularly in the DeepTech sector, which encompasses advanced technologies such as artificial intelligence, biotechnology, and advanced manufacturing.

Funding Structure

The EIC Accelerator provides a unique funding model known as blended finance, which combines grants and equity investments to support startups through different stages of their development. Under this framework, companies can receive:

• Grant Funding: Up to €2.5 million is available in the form of non-repayable grants. This funding is typically allocated to support the development of innovative products or services, covering costs associated with prototyping, testing, and piloting.
• Equity Investment: The program also offers equity funding up to €15 million until 2024 and up to €10 million starting from 2025. This equity investment is crucial for companies looking to scale their operations, expand their market reach, and attract further investment from private sectors.

Purpose of the EIC Accelerator

The primary goal of the EIC Accelerator is to enhance the European startup ecosystem by facilitating access to funding for innovative projects that have the potential to disrupt existing markets or create entirely new ones. By providing both grants and equity, the program significantly lowers the financial barriers for high-tech startups, allowing them to focus on innovation and growth. In addition, the EIC Accelerator plays a vital role in improving the visibility of European startups, enabling them to attract additional investments and partnerships from private investors.

Role in Scaling Companies

The EIC Accelerator not only provides financial support but also offers strategic guidance and mentorship. This comprehensive support system helps companies scale efficiently, navigate market challenges, and refine their business models. By bridging the gap between early-stage innovation and market readiness, the program enables startups to secure the necessary funding and partnerships to thrive in competitive landscapes.

Spotlight on Raidium and the FoundRa Project

Company Overview

Raidium, a French startup, emerged as a prominent winner of the EIC Accelerator, securing funding for its innovative project, FoundRa, which stands for Foundation Model-Based Biomarker Platform for Radiology and Clinical Trials. Raidium focuses on leveraging advanced machine learning techniques to revolutionize the field of radiology and clinical trials.

Project Description: FoundRa

The FoundRa project is designed to develop a sophisticated platform that utilizes foundation models—large pre-trained machine learning models that can be fine-tuned for specific tasks—to identify and validate biomarkers in radiological images. The platform aims to enhance the accuracy and efficiency of diagnosing diseases, thereby improving patient outcomes and streamlining the clinical trial process.

Technology Fundamentals

The technology underlying FoundRa involves advanced artificial intelligence and machine learning algorithms. By employing foundation models, Raidium's platform can analyze vast datasets of radiological images, extracting meaningful patterns and insights that may not be apparent through traditional analysis methods. This approach enables the identification of biomarkers that serve as indicators of disease progression or treatment efficacy, which are crucial for personalized medicine.

The application of such technology has the potential to significantly reduce the time and cost associated with clinical trials, as it allows for more rapid identification of suitable patient populations and enhances the reliability of trial outcomes. Furthermore, by improving diagnostic accuracy, the platform can aid healthcare professionals in making more informed decisions, ultimately leading to better patient care.

Conclusion

The EIC Accelerator program serves as a cornerstone for fostering innovation in the European DeepTech ecosystem. By providing blended funding solutions and strategic support, it enables startups like Raidium to bring their groundbreaking ideas to fruition. The FoundRa project exemplifies the potential of advanced technology to transform healthcare, highlighting the critical role that the EIC Accelerator plays in nurturing the next generation of innovative companies in Europe.

2 The Funding Rounds

# Raidium: French Medical Imaging Innovator Secures EIC Accelerator Funding

Raidium, a Paris-based company specializing in 3D medical imaging models for radiology, has established itself as a significant player in the medical technology sector after receiving EIC Accelerator funding in 2024 and subsequently raising substantial private investment.

EIC Accelerator Funding

Raidium was selected for the prestigious European Innovation Council (EIC) Accelerator funding program in mid-2024. The company was among the successful applicants from the March 13, 2024 cut-off, which was announced in July 2024. The EIC Accelerator is a highly competitive program aimed at supporting deep-tech and high-impact ventures across Europe.

While the exact funding amount specifically allocated to Raidium through the EIC Accelerator program is not explicitly stated in the available information, typical EIC Accelerator funding packages average around €5.45 million per company, combining grants and equity investments.

Private Funding Success

Following their EIC Accelerator selection, Raidium announced a significant seed funding round on November 28, 2024, raising €16 million. This round was co-led by Newfund and Kurma Partners, with participation from several other investors including:

• Galion.exe
• Founders Future
• Debiopharm
• Techmind
• The European Innovation Council and SMEs Executive Agency (EISMEA)

The seed round came approximately four months after Raidium's selection for the EIC Accelerator program, demonstrating how the EIC endorsement likely helped catalyze additional private investment.

Company Focus and Technology

Founded by Paul Herent and Pierre Manceron, Raidium is developing advanced technology for the medical imaging sector:

• A 3D Large Vision Language foundation model specifically designed for analyzing CT scans and MRIs
• Training on a proprietary dataset provided by their partner, Centre Imagerie du Nord
• An innovative user interface prototype tailored for radiologists

The company's mission is to enhance radiologists' efficiency and effectiveness in medical imaging, allowing for the creation of new biomarkers that can benefit patients.

Funding Utilization

Raidium plans to use the €16 million seed funding to:

Market Context

Raidium's funding success comes amid a gradual improvement in private capital markets. According to the Q4 2024 PitchBook-NVCA Venture Monitor report from January 2025, private capital markets were experiencing concurrent improvement in both valuations and round sizes across series for the first time in years.

As of May 2025, there is no public information available regarding any exit events such as IPOs, buyouts, or acquisitions involving Raidium, suggesting the company remains in its growth and development phase following its recent funding rounds.

Sources

• Latest EIC Accelerator Results - Rasph
• French Startup Raidium Raises €16M Seed Funding to Revolutionize 3D Medical Imaging in Radiology - AI Insider
• Raidium was funded by the EU via EIC Accelerator | Nordic 9
• EIC Accelerator – 68 deep-tech start-ups in the latest funding round
• France's Raidium secures €16M funding - Silicon Canals

3 The Press Releases

Raidium's Breakthroughs Post-EIC Accelerator Funding Paris-based Raidium, a winner of the March 2024 EIC Accelerator, has leveraged its €2.5M grant and future equity commitment to accelerate its AI-driven radiology innovations. The company specializes in foundation models for precision radiology, focusing on biomarker research and clinical trial optimization.

Key Developments:

• Funding Milestone: Secured a €16M seed round co-led by Newfund and Kurma Partners, with participation from Galion.exe, Founders Future, Debiopharm, Techmind, and EISMEA.
• Product Deployment: Prototyping an AI-native PACS viewer integrating large vision-language models (LVLM) to automate tumor measurements (RECIST 1.1 standards).
• Partnerships & Recognition: Joined StartX’s Spring 2025 cohort and named among STATION F’s Future 40 startups. Awarded Grand Prix at France’s I-Lab Innovation Contest under the #France2030 initiative.
• Technology Showcase: Released ONCOPILOT, an AI model achieving radiologist-level precision in tumor segmentation (manuscript published on arXiv). Selected for Microsoft’s GenAI Studio for LVLM development.

---

Sources
Raidium's EIC Accelerator Announcement
Raidium's Seed Round Update
ONCOPILOT Video Release
I-Lab Innovation Contest Win
Microsoft GenAI Studio Selection

4 The Technology Advancements

Raidium's Post-EIC Accelerator Advancements in Precision Radiology

Paris-based Raidium has demonstrated significant progress since securing EIC Accelerator funding earlier in 2024, marked by technological enhancements, strategic partnerships, and commercial traction. Below is a detailed breakdown of their advancements:

---

Current Capabilities

Raidium’s core offering is a 3D Large Vision Language foundation model designed for analyzing CT scans and MRIs. The AI-native platform provides:

• Automated 3D segmentation and biomarker analysis, operating 2,500× faster than manual methods.
• Multimodal integration of imaging and clinical text data for scalable biomarker discovery.
• An interactive viewer dubbed the “GPT of radiology,” enabling real-time collaboration and automated report generation.

---

Post-Funding Advancements (Since March 2024)

---

Technology Demonstrations & Market Validation

• Clinical Collaborations: Partnered with AP-HP (France’s largest hospital network) and Centre Imagerie du Nord for real-world validation.
• Pharmaceutical Contracts: Secured undisclosed pharma clients for biomarker research through Amgen’s BioLabs program, with additional projects under NDAs.
• Public Showcases: Released a video demonstration of ONCOPILOT’s lesion-tracking capabilities at industry events, alongside participation in Microsoft’s GenAI Studio program as a laureate.

---

Intellectual Property & Research Outputs

While no new patents are explicitly cited post-March 2024:

• The arXiv manuscript establishes technical leadership in tumor segmentation accuracy compared to radiologists.[⁴]⁠⁠⁠⁠⁠⁠⁠
• Continued R&D focus on expanding multimodal capabilities under EIC grants.[¹0]

---

Strategic Positioning Ahead of U.S. Expansion

Raidium plans to open U.S offices while deepening EU partnerships,[¹0] leveraging StartX Spring 2025 cohort mentorship to refine commercialization strategies.[⁴] Recent accolades include selection among STATION F Future 40 startups,[⁴] reinforcing its status as a radiology AI frontrunner.

---

Sources: BiopharmaTrend | AI Insider | Tech.eu | Raidium.eu | TFN

5 The Partnerships and Customers

Raidium: Enhancing Radiology with Strategic Partnerships and Funding

Raidium, a French startup specializing in 3D medical imaging models for radiology, has recently gained significant recognition and funding, positioning itself for substantial growth and innovation in the medical technology sector. This includes winning the EIC Accelerator funding program in March 2024 and raising €16 million in a seed funding round.

Partnerships and Customers

Raidium has associated itself with several key partners and investors, including:

• Centre Imagerie du Nord: Provides a proprietary dataset for training Raidium's AI models.
• Newfund and Kurma Partners: Co-led the recent €16 million seed funding round.
• Galion.exe, Founders Future, Debiopharm, Techmind: Participated in the seed funding round.
• European Innovation Council and SMEs Executive Agency (EISMEA): Contributed to the funding.

These partnerships underscore Raidium's commitment to enhancing radiologists' efficiency and effectiveness in medical imaging.

New Partners and Customers

While there is no specific mention of new partners or customers in the recent updates, Raidium's inclusion in prestigious programs and networks indicates an expanding network:

• StartX Spring 2025 cohort: Joining this network enhances Raidium's access to mentorship and community support.
• STATION F Future 40 2024: Recognition as one of the top startups highlights Raidium's potential and growth.

Nature of New Relationships and Purpose

Raidium's new relationships, such as the EIC Accelerator funding and the StartX cohort, are focused on accelerating its technology development and market expansion. These partnerships aim to enhance Raidium's AI models for radiology, particularly its ONCOPILOT and LVLM (Large Vision Language Model) foundation models. The purpose is to revolutionize 3D medical imaging, improve patient care, and increase radiologists' efficiency.

Positioning in the Market

These relationships position Raidium as a leader in innovative radiology solutions, particularly in AI-driven medical imaging. By leveraging partnerships and funding, Raidium is poised to scale its operations, enhance its technology offerings, and expand its market presence.

Advancements and Scaling

The funding and partnerships will aid Raidium in several key areas: - Technology Advancements: Developing more sophisticated AI models for better tumor segmentation and RECIST 1.1 evaluations.

• Scaling Operations: Expanding its product offerings and team to meet growing demand in the medical imaging sector.
• Market Expansion: Increasing its presence in both industrial and academic biomarker research projects.

Raidium's strategic partnerships and funding are central to its mission of democratizing precision radiology and improving patient outcomes through cutting-edge AI solutions.

---

Sources: - Raidium

• French Startup Raidium Raises €16M Seed Funding
• EIC Accelerator – 71 companies selected

6 The Hiring and Company Growth

Raidium: Post-EIC Accelerator Funding Growth

Raidium, a French company, successfully secured funding through the European Innovation Council (EIC) Accelerator program in March 2024. Unfortunately, there is limited specific information available about Raidium's team size, hiring status, or recent management changes directly related to the EIC funding. However, securing such prestigious funding typically indicates significant growth opportunities and strategic hiring to support innovation.

Current Team and Hiring Status

No specific details are available regarding Raidium's current headcount or recent hiring activities. However, companies that receive EIC funding often experience an increase in hiring to support their innovative projects.

Team Growth and Expansion

The EIC funding typically enables companies to accelerate their growth by expanding their teams with key hires in areas such as technology, research, and development. These new team members are crucial for scaling and implementing innovative projects, ensuring the company's future success.

Impact of New Team Members

New hires play a pivotal role in driving innovation and growth within companies like Raidium. They bring fresh perspectives and expertise, helping to scale operations, enhance product offerings, and navigate competitive markets.

Management Changes

There is no specific information available about recent changes in Raidium's management or founding team. Significant funding events often lead to strategic adjustments, but details about such changes are not publicly disclosed for Raidium.

In summary, while specific details about Raidium's hiring activities or team size are not available, the EIC funding is a strong indicator of the company's potential for growth and innovation in the future.

Sources:

• EIC Accelerator – 68 deep-tech start-ups in the latest funding round
• EIC Accelerator October 2024 Winners
• The winners of the last EIC Accelerator funding round

7 The Media Features and Publications

Media Coverage and Public Engagement of Raidium Post-EIC Accelerator Funding Raidium, a French deep-tech startup specializing in AI-driven radiology solutions, has garnered significant media attention and institutional recognition since securing EIC Accelerator funding in March 2024. Below is an overview of their public engagements, awards, and coverage:

Media Features & Publications

• EIC Accelerator Announcement: Raidium was highlighted as a winner of the March 2024 EIC Accelerator call, receiving €2.5M in grants and eligibility for future equity investments.
• I-Lab Innovation Contest: Named a Grand Prix winner under France’s #France2030 initiative for its work on next-generation radiology workflows.
• STATION F Future 40: Listed among the top 40 startups at Paris’ Station F campus in 2024.
• Microsoft GenAI Studio Recognition: Selected as one of 15 laureates for developing a large vision-language model (LVLM) to enhance precision radiology.

Podcasts & Interviews

While no direct podcasts featuring Raidium’s team were identified through available sources, the company actively shares updates via its website and press releases. Notably absent are third-party podcast interviews or dedicated episodes detailing their technology.

Conferences & Events

• StartX Spring 2025 Cohort: Accepted into this mentorship-driven program to expand its network and accelerate growth.
• Academic Collaborations: Demonstrated ONCOPILOT—their AI model for tumor segmentation—through published manuscripts on arXiv and video releases showcasing clinical-grade precision.

Event Participation & Awards Ceremonies

Raidium emphasizes R&D milestones over frequent conference appearances but has engaged with high-profile programs like:

• French I-Lab Awards, where it secured government backing for innovative radiology tools.
• EIC Community Updates, leveraging EU funding announcements to amplify visibility among investors.

---

Sources
Raidium News | EIC Accelerator March 2024 Results | Latest EIC Results (Feb 2025) | Europa.eu Announcement